- Home
- GENI vs BCRX Comparison
GENI vs BCRX Comparison
Compare GENI & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENI | BCRX |
|---|---|---|
| Founded | 2016 | 1986 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 2.0B |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | GENI | BCRX |
|---|---|---|
| Price | $6.29 | $8.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 11 |
| Target Price | $10.76 | ★ $20.55 |
| AVG Volume (30 Days) | ★ 6.3M | 4.6M |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 381.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | $51.72 | N/A |
| Revenue Next Year | $28.00 | $3.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.83 | $6.23 |
| 52 Week High | $11.58 | $11.22 |
Technical Indicators
Market Signals| Indicator | GENI | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 54.40 |
| Support Level | $6.01 | $8.09 |
| Resistance Level | $6.79 | $8.60 |
| Average True Range (ATR) | 0.38 | 0.28 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 30.77 | 85.22 |
Price Performance
Historical ComparisonAbout GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas: Sports Technology and Services; Betting Technology, Content, and Services; and Media Technology, Content, and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content, and Services division. Geographically, the company derives a majority of its revenue from America.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.